Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer

NPJ Breast Cancer. 2021 Nov 24;7(1):149. doi: 10.1038/s41523-021-00359-w.

Federica Miglietta^{1

2}, Gaia Griguolo^{1

2}, Michele Bottosso^{1

2}, Tommaso Giarratano², Marcello Lo Mele³, Matteo Fassan^{4

5}, Matilde Cacciatore⁶, Elisa Genovesi^{1

2}, Debora De Bartolo⁴, Grazia Vernaci^{1

2}, Ottavia Amato^{1

2}, PierFranco Conte^{1

2}, Valentina Guarneri^{7

8}, Maria Vittoria Dieci^{1

2}

¹ Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Padova, Italy.
² Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy.
³ Surgical Pathology Unit, University Hospital of Padua, Padua, Italy.
⁴ Department of Medicine (DIMED), Surgical Pathology & Cytopathology Unit, University of Padua, Padua, Italy.
⁵ Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
⁶ Department of Pathology and Molecular Genetics, Treviso General Hospital, Treviso, Italy.
⁷ Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Padova, Italy. valentina.guarneri@unipd.it.
⁸ Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy. valentina.guarneri@unipd.it.

No abstract available

Publication types